Reasons Why Hedge Funds Favor Insulet Corp (PODD)
As of the close of play on January 28, Insulet Corporation (NASDAQ:PODD) carried a highly bullish consensus view.
Insulet Corp (PODD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 113,083 | $32,142,712 | 0.71% | |
| 2. | Impax Asset Management Ian Simm | 9,667 | $2,747,748 | 0.02% | |
| 3. | Ayrshire Capital Management John Nevin Jr. | 5,064 | $1,439,306 | -74% | 0.66% |
| 4. | Bayforest Capital Theodoros Tsagaris | 775 | $220,286 | -46% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $311.73 | 962 | $299,884.26 | 4,591 | 2025-12-05 | Filing | |
| $206.00 | 100 | $20,600.00 | 13,314 | 2024-08-29 | Filing | |
| $168.92 | 1 | $168.92 | 4,032 | 2023-09-19 | Filing | |
| $181.41 | 5,550 | $1,006,825.50 | 34,177 | 2023-08-28 | Filing | |
| $304.75 | 3,300 | $1,005,675.00 | 12,221 | 2023-05-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $293.09 | 1,851 | $542,509.59 | 2,158 | 2025-12-15 | Filing | |
| $347.49 | 687 | $238,725.63 | 3,456 | 2025-09-08 | Filing | |
| $348.81 | 797 | $278,001.57 | 3,890 | 2025-09-08 | Filing | |
| $332.23 | 4,263 | $1,416,296.49 | 16,736 | 2025-08-21 | Filing | |
| $320.00 | 1,343 | $429,760.00 | 4,143 | 2025-08-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,701,472 | $2,473,306,401 | 0.04% | |
| 2. | 2,048,369 | $582,228,404 | 0.48% | |
| 3. | 551,133 | $157,128,018 | 0.13% | |
| 4. | 234,022 | $66,518,413 | 0.01% | |
| 5. | 225,429 | $64,075,939 | 0.1% |
News See All
12 Best Medical Devices Stocks According to Hedge Funds
It is challenging to identify segments within the markets that appear to be defensive plays, yet offer innovation potential.
Bernstein Reduces Firm’s PT on Insulet (PODD) Stock
Insulet Corporation (NASDAQ:PODD) is one of the Best Fundamental Stocks to Buy According to Analysts.
13 Best Fundamental Stocks to Buy According to Analysts
Goldman Sachs Research anticipates that the US stocks will post a fourth-straight year of gains in 2026.
What Provides InsuletCorp. (PODD) With a Durable Competitive Advantage?
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026
Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026.
10 Best Growth Stocks to Buy in 2026
On December 10, Meghan Shue, Wilmington Trust chief investment strategist, appeared on CNBC's 'The Exchange'.
Insulet Corporation (NASDAQ:PODD) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Insulet Corporation Third Quarter Earnings Call. [Operator Instructions] As a reminder, this conference call is being recorded.
RBC Capital Lifts Insulet (PODD) PT to $365 on Strong Momentum, Q3 Guidance Optimism
Insulet Corporation (NASDAQ:PODD) is one of the best NASDAQ growth stocks to buy for the next 5 years.
10 Best NASDAQ Growth Stocks to Buy for the Next 5 Years
On October 24, Peter Oppenheimer, Chief Global Equity Strategist at Goldman Sachs, appeared on CNBC to suggest that the tech rally is grounded in fundamentals, not speculation, though rising excitement...
Hedge Fund Resource Center Billionaire Hedge Funds
